Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2018

Nov 6, 2018

29745_dirs_2018-11-06_b77bd182-b171-468a-b3b8-db794b56527a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-11-03

Reporting Person: Norton Johna (Senior VP, Global Quality)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-03 Common Stock M 3133 Acquired 19225 Direct
2018-11-03 Common Stock F 1366 $106.75 Disposed 17859 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-11-03 Restricted Stock Unit $ M 3133 Disposed 2018-11-03 Common Stock (3133.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 487 Indirect
Common Stock 34 Indirect
Common Stock 2535 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.